Apr 22
|
Morning Bid:'Major loser' reporting for duty
|
Apr 22
|
Drug Companies Step Up 'Make in America' Plans to Counter Tariffs
|
Apr 22
|
Swiss drugmaker Roche leans into Trump tariff formula with $50 billion promise to invest in U.S.
|
Apr 22
|
Roche announces $50bn US investment in pharma and diagnostics
|
Apr 22
|
Trending tickers: Nvidia, Tesla, Roche, Novo Nordisk and Fresnillo
|
Feb 20
|
Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology
|
Feb 19
|
Q4 2024 Halozyme Therapeutics Inc Earnings Call
|